Effects of Nicotine Administration on the Expression Levels of alpha7 Nicotinic Acetylcholine Receptor, miRNA-124, STAT3, and Inflammatory Factors in Lung Tissue

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Nicotine, a major alkaloid in tobacco, interacts with nicotinic acetylcholine receptors (nAChRs), notably alpha7 nAChR, which are key modulators of inflammatory signaling. The α7nAChR regulates the release of pro-inflammatory cytokines, a process modulated by microRNA-124 (miR-124), which downregulates inflammatory mediators. Additionally, STAT3, a transcription factor activated by cytokines, is inhibited by miR-124. This study aimed to evaluate the effects of nicotine on the expression of α7nAChR, miRNA-124, STAT3 protein, and inflammatory cytokines (IL-10 and MCP-1) in rat lung tissue. Methods Adult male Wistar rats were treated with varying doses of nicotine. Lung tissues were collected for molecular analysis. Gene expression levels were examined using qRT-PCR, while protein levels were assessed through Western blotting. Cytokine concentrations were measured with ELISA kits. Results Nicotine exposure led to a dose-dependent increase in α7nAChR mRNA and protein expression. Elevated nicotine levels significantly enhanced STAT3 protein and altered the expression of miRNA-124. ELISA results showed changes in inflammatory (MCP-1) and anti-inflammatory (IL-10) cytokine levels. Statistical analysis confirmed the significance at (p < 0.05). Conclusion Nicotine modulates both inflammatory and anti-inflammatory signaling pathways in rat lung tissue, suggesting a dual regulatory role through α7nAChR and associated molecular mediators. This interaction between α7-nAChR, miR-124, and STAT3 forms a crucial signaling pathway linking cholinergic activity to neuroinflammation regulation, suggesting potential therapeutic targets for neurodegenerative diseases driven by inflammation and neuronal injury.

Article activity feed